What is the primary purpose of this 10-Q filing?

This 10-Q filing is a quarterly report filed by Boston Scientific Corporation with the SEC. Its purpose is to provide investors and the public with an update on the company's financial performance and operational activities for the period ending September 29, 1997.

What specific financial details can I find in this filing?

While the provided text is a directory listing and does not contain the full financial statements, a complete 10-Q filing would typically include unaudited financial statements (income statement, balance sheet, cash flow statement), management's discussion and analysis of financial condition and results of operations, and details on any significant legal proceedings or risk factors.

Where can I find the complete financial data for Boston Scientific from this period?

To access the complete financial data, you would need to locate and review the actual 10-Q filing document (likely the .txt or a linked HTML version from the provided directory) on the SEC's EDGAR database or through financial data providers that archive these filings.

What are the key metrics investors should look for in a 10-Q filing like this one?

Investors typically focus on revenue growth, gross profit margins, operating income, net income, earnings per share (EPS), cash flow from operations, and any significant changes in debt or equity. Developments in product pipelines, market share, and competitive landscape are also important qualitative factors.

BSX 10-Q Quarterly Report Q3 FY1997 — Revenue, Net Income, EPS

Summary

Boston Scientific Corporation's (BSX) 10-Q filing for the period ending September 29, 1997, reveals a company actively engaged in its core business of developing and marketing medical devices. While the provided excerpt does not contain detailed financial statements or operational metrics, it indicates that the company is a public entity regularly submitting financial disclosures to the SEC. Investors would typically look for revenue growth, profitability, new product introductions, and market expansion within these filings to assess the company's performance and future prospects.

Key Highlights

1Boston Scientific Corporation (BSX) filed a 10-Q quarterly report for the period ending September 29, 1997.
2The filing indicates regular disclosure practices by the company to the SEC.
3The report covers the operational and financial activities of BSX during the third quarter of 1997.
4Investors would analyze this filing for key financial performance indicators.
5Key areas of interest for investors would include revenue, net income, and earnings per share.
6Information on product development, regulatory approvals, and market penetration would also be crucial.
7The filing is part of BSX's ongoing commitment to transparency with shareholders and the investment community.

BOSTON SCIENTIFIC CORP Quarterly Report for Q3 Ended Sep 30, 1997

Summary

Key Highlights

Frequently Asked Questions